A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC
Public ClinicalTrials.gov record NCT02364999. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 3 RANDOMIZED, DOUBLE-BLIND STUDY OF PF- 06439535 PLUS PACLITAXEL-CARBOPLATIN AND BEVACIZUMAB PLUS PACLITAXEL -CARBOPLATIN FOR THE FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multinational, double-blind, randomized, parallel-group Phase 3 clinical trial evaluating the efficacy and safety of bevacizumab-Pfizer plus paclitaxel and carboplatin versus bevacizumab-EU plus paclitaxel and carboplatin in first-line treatment for patients with advanced (unresectable, locally advanced, recurrent or metastatic) non-squamous NSCLC.
Study identification
- NCT ID
- NCT02364999
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 719 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2015 (Actual)
- Primary completion
- May 2017 (Actual)
- Completion
- Dec 2017 (Actual)
- Last update posted
- Feb 7, 2019
2015 – 2017
United States locations
- U.S. sites
- 19
- U.S. states
- 8
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southern Cancer Center, PC | Daphne | Alabama | 36526 | — |
| Southern Cancer Center, PC | Mobile | Alabama | 36607 | — |
| Southern Cancer Center, PC | Mobile | Alabama | 36608 | — |
| Beaver Medical Group, L.P. | Highland | California | 92346 | — |
| Cancer Center of Central Connecticut | New Britain | Connecticut | 06052 | — |
| Cancer Center of Central Connecticut | Southington | Connecticut | 06489 | — |
| Phoebe Putney Memorial Hospital | Albany | Georgia | 31701 | — |
| Swedish Covenant Hospital | Chicago | Illinois | 60625 | — |
| Meritus Center for Clinical Research | Hagerstown | Maryland | 21742 | — |
| Holy Cross Hospital Resource Center | Silver Spring | Maryland | 20902 | — |
| Maryland Oncology & Hematology, PA | Silver Spring | Maryland | 20904 | — |
| Holy Cross Hospital, Hospital Pharmacy | Silver Spring | Maryland | 20910 | — |
| Holy Cross Hospital | Silver Spring | Maryland | 20910 | — |
| Maryland Oncology & Hematology, PA | Wheaton | Maryland | 20902 | — |
| St. Joseph's Regional Medical Center | Paterson | New Jersey | 07503 | — |
| Millennium Oncology | Houston | Texas | 77090 | — |
| Millennium Oncology | Kingwood | Texas | 77339 | — |
| Millennium Oncology | Shenandoah | Texas | 77384 | — |
| Millennium Oncology | The Woodlands | Texas | 77380 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 244 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02364999, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 7, 2019 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02364999 live on ClinicalTrials.gov.